Companion Animal Product & Promotions Guide

May 2022

Animal Health Solution - a Henry Schein Animal Health magazine for veterinary professionals

Issue link: https://www.e-digitaleditions.com/i/1465939

Contents of this Issue

Navigation

Page 6 of 23

Important Safety Information: The most common adverse events in decreasing order of reported frequency are: decreased appetite, depression/lethargy, shaking/shivering/ tremor, vomiting, restlessness and anxiety, seizures, aggression, diarrhea, mydriasis, vocalization, weight loss, panting, confusion, incoordination, and hypersalivation. Reconcile® chewable tablets are contraindicated for dogs with a history of seizures or when used with MAOIs. Reconcile chewable tablets are indicated for the treatment of canine separation anxiety in conjunction with a behavior modification plan. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Visit Reconcile.com to view full prescribing information. Don't miss this tasty, tempting limited-time offer! Flavored, chewable Reconcile® (fluoxetine hydrochloride) tablets, in conjunction with the BOND ™ training program, are clinically proven to help dogs that experience separation anxiety. TALK TO YOUR DISTRIBUTOR REPRESENTATIVE TODAY ABOUT THIS LIMITED-TIME OFFER! Available only while supplies last. Allow a minimum of four weeks for fulfillment. Visit PRNPromoClaim.com for more information and submission instructions. Buy four (4) bottles of Reconcile® and receive one (1) Busy Buddy® Twist 'n Treat ™ , size medium, for free. Offer runs from May 1, 2022 through June 30, 2022. PRN® and Reconcile® are registered trademarks of Pegasus Laboratories, Inc. NOW AVAILABLE IN 90-COUNT BOTTLE SIZES!

Articles in this issue

Links on this page

Archives of this issue

view archives of Companion Animal Product & Promotions Guide - May 2022